TISSEEL 2 ml
TISSEEL 2 ml is a medicine authorised by Swissmedic under authorisation number 52618. The authorisation holder is Baxter AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 June 1994 and the authorisation is valid without a time limit. ATC code B02BC10 places the medicine in the group Antihemorrhagics.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 5 | TISSEEL 2 ml, 2 Fertigspritzen | B | 12 October 2012 |
| 6 | TISSEEL 4 ml, 2 Fertigspritzen | B | 12 October 2012 |
| 7 | TISSEEL 10 ml, 2 Fertigspritzen | B | 12 October 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 2 x 1 ml | Spritze(n) | B02BC10 | 06.99.0. | B |
| 5 | 2 x 2 ml | Spritze(n) | B02BC10 | 06.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is TISSEEL 2 ml authorised in Switzerland?
Yes. TISSEEL 2 ml is authorised by Swissmedic under authorisation number 52618, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does TISSEEL 2 ml have?
TISSEEL 2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of TISSEEL 2 ml?
The authorisation holder is Baxter AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.